Procarta announces €1.5 million investment for new class of antibiotics to combat antimicrobial resistance
08-Mar-2019 -
Procarta Biosystems, a privately held UK-based biotech company, announced €1.5m of new funding from the Novo Holdings REPAIR Impact Fund to support development of novel therapies to combat antimicrobial resistance (AMR). The new funding will be used todevelop a pipeline of an entirely new class ...
antibiotics
antimicrobial resistance